Vasavada Megha M, Martinez Brittany, Wang Jianli, Eslinger Paul J, Gill David J, Sun Xiaoyu, Karunanayaka Prasanna, Yang Qing X
Departments of Radiology, Pennsylvania State University College of Medicine, Hershey, PA, USA.
Departments of Neurology, Pennsylvania State University College of Medicine, Hershey, PA, USA.
J Alzheimers Dis. 2017;59(1):359-368. doi: 10.3233/JAD-170310.
Olfactory deficits are present in early Alzheimer's disease (AD) and mild cognitively impaired (MCI) patients. However, whether these deficits are due to dysfunction of the central or peripheral olfactory nervous system remains uncertain. This question is fundamentally important for developing imaging biomarkers for AD using olfactory testing.
This study sought to use olfactory functional magnetic resonance imaging (fMRI) to further demonstrate the involvement of the central olfactory system in olfactory deficits in MCI and AD.
We investigated the central olfactory system in 27 cognitively normal controls (CN), 21 MCI, and 15 AD subjects using olfactory fMRI with an odor-visual association paradigm during which a visual cue was paired with lavender odorant (odor condition) or odorless air (no-odor condition).
The CN subjects had significantly greater activated volume in the primary olfactory cortex during both the odor and no-odor conditions compared to either the MCI or AD groups (p < 0.05). No significant differences were observed between the odor and no-odor conditions within each group. No-odor condition activation in AD and MCI correlated with the cognitive and olfactory assessments.
The no-odor condition, allowing investigation of activation patterns when the peripheral olfactory system was not directly involved, elicited the same functional response as the odor condition for each of the three groups. Thus, the olfactory activation deficits present in AD and MCI patients are most likely caused by degeneration of the central olfactory nervous system.
嗅觉缺陷在早期阿尔茨海默病(AD)和轻度认知障碍(MCI)患者中存在。然而,这些缺陷是由于中枢还是外周嗅觉神经系统功能障碍仍不确定。这个问题对于利用嗅觉测试开发AD的成像生物标志物至关重要。
本研究旨在使用嗅觉功能磁共振成像(fMRI)进一步证明中枢嗅觉系统参与MCI和AD患者的嗅觉缺陷。
我们使用嗅觉fMRI和气味-视觉关联范式对27名认知正常对照者(CN)、21名MCI患者和15名AD患者的中枢嗅觉系统进行了研究,在此范式中,视觉提示与薰衣草气味剂(气味条件)或无气味空气(无气味条件)配对。
与MCI或AD组相比,CN受试者在气味和无气味条件下初级嗅觉皮层的激活体积均显著更大(p<0.05)。每组内气味和无气味条件之间未观察到显著差异。AD和MCI患者在无气味条件下的激活与认知和嗅觉评估相关。
无气味条件允许在不直接涉及外周嗅觉系统时研究激活模式,对三组中的每一组都引发了与气味条件相同的功能反应。因此,AD和MCI患者中存在的嗅觉激活缺陷很可能是由中枢嗅觉神经系统的退化引起的。